Healthcare -
Biotechnology - NASDAQ - US
$ 0.549
1.9 %
$ 2.6 M
Market Cap
-0.11
P/E
PCSA - RESEARCH & DEVELOPMENT
Research & Development PCSA - Processa Pharmaceuticals, Inc.
5.8 M
LAST VALUE
-8.17%
2 YEAR CAGR
13.45%
5 YEAR CAGR
36.04%
10 YEAR CAGR